Skip to main content
. Author manuscript; available in PMC: 2019 Jul 9.
Published in final edited form as: Pediatr Crit Care Med. 2012 Nov;13(6):625–631. doi: 10.1097/PCC.0b013e318260114e

Table 2.

Univariate analyses of predictors of mechanical ventilator use among 10,173 U.S. children hospitalized with seasonal influenza.

n (%) OR (95% CI) P
Gender 0.72
 Male (N=5,760) 527 (9.2) Reference
 Female (N=4,413) 413 (9.4) 1.02 (0.90 – 1.17)
Age <0.001
 <2 months (N=1,412) 97 (6.9) Reference
 2–11 months (N=2,317) 264 (11) 1.74 (1.37 – 2.22)
 1–4 years (N=3,252) 287 (8.8) 1.31 (1.03 – 1.67)
 5–11 years (N=2,133) 184 (8.6) 1.28 (0.99 – 1.65)
12–17 years (N=1,059) 108 (10) 1.54 (1.16 – 2.05)
Race <0.001
 White (N=6,393) 585 (9.2) Reference
 Black (N=2,573) 191 (7.4) 0.80 (0.67 – 0.94)
 Non-White/non-Black (N=1,207) 164 (14) 1.56 (1.30 – 1.88)
Primary payer 0.70
 Private (N=2,620) 247 (9.4) Reference
 Non-Private (N=7,553) 693 (9.2) 0.97 (0.83 – 1.13)
Season 0.28
 2006 – 07 (N=2,870) 280 (9.8) Reference
 2007 – 08 (N=4,336) 378 (8.7) 0.88 (0.75 – 1.04)
 2008 – 09 (N=2,967) 282 (9.5) 0.97 (0.82 – 1.16)
Health status
 Previously healthy (N=4,415) 205 (4.6) Reference
 Non-ACIP condition a (N=713) 92 (13) 3.04 (2.35 – 3.94) <0.001
 ACIP-defined condition b
  Cardiovascular disease (N=650) 158 (24) 3.59 (2.96 – 4.36) <0.001
  Neurological disease (N=1,425) 334 (23) 4.11 (3.55 – 4.77) <0.001
  Chronic lung disease (N=899) 195 (22) 3.17 (2.66 – 3.78) <0.001
  Immunosuppression (N=1,008) 97 (9.6) 1.05 (0.84 – 1.31) 0.66
  Metabolic disease (N=343) 48 (14) 1.63 (1.19 – 2.23) 0.002
  Renal disease (N=109) 13 (12) 1.34 (0.74 – 2.39) 0.33
  Hepatic disease (N=82) 21 (26) 3.44 (2.09 – 5.67) <0.001
  Hematologic disease (N=410) 3 (0.7) 0.07 (0.02 – 0.22) <0.001
  Asthma (N=1,861) 135 (7.2) 0.73 (0.60 – 0.88) 0.001
  Chronic aspirin therapy (N=23) 0
Bacterial pneumonia (N=567) 199 (35) 6.47 (5.36 – 7.81) <0.001
a

Compared to previously healthy children.

b

Compared to children without each risk factor.